PRF Technologies
PRFX | NASDAQ
$0.69
-$0.09 (-11.83%)
At close: Nov 16, 2026, 4:00 PM ET
$0.75
+$0.06 (+8.70%)
After-hours:
Nov 16, 2026, 4:43 PM ET
PRF Technologies Company Profile
Company profile explainedCompany Profile
PRF Technologies Ltd. operates as a specialized pharmaceutical company, currently in the clinical development stage, with a focus on pioneering treatments that deliver sustained post-surgical pain management. Central to its pipeline is PRF-110, a distinctive clear, viscous, oil-based solution. This innovative product is engineered for direct application into surgical incisions, aiming to provide targeted and prolonged alleviation of discomfort following operations. PRF-110 is presently undergoing assessment in two pivotal Phase 3 clinical trials, specifically for individuals recovering from bunionectomy and hernia repair procedures. The company, which was originally incorporated in 2007 under the name PainReform Ltd., maintains its headquarters in Tel Aviv, Israel.
Key Executives
| Name | Position |
|---|---|
| Efraim Cohen-Arazi | Interim CEO & Director |
| Eyal Broder | Chief Financial Officer |
| Sigal Aviel | Chief Operating Officer |
| Ehud Geller | Executive Chairman |
| Rita Keynan | Vice President of Pharmaceutical Operations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 23, 2026 | 6-K | Filing |
| Sep 28, 2026 | 6-K | Filing |
| Sep 24, 2026 | SC 13D | Filing |
| Sep 16, 2026 | 6-K | Filing |
| Sep 09, 2026 | 6-K | Filing |
| Sep 03, 2026 | EFFECT | Filing |
| Sep 03, 2026 | POS AM | Filing |
| Sep 03, 2026 | 6-K | Filing |
| Jul 27, 2026 | 6-K | Filing |
| Jul 21, 2026 | 6-K | Filing |
PRF Technologies
| Country | Israel |
| IPO Date | Sep 1, 2020 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 7 |
| CEO | Efraim Cohen-Arazi |
Contact Details
65 Yigal Alon Street Tel Aviv,
TA 6744316 Israel
Stock Details
| Ticker Symbol | PRFX |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001801834 |
| CUSIP Number | M77798201 |
| ISIN Number | IL0011651580 |
| SIC Code | 2834 |
Add to Watchlist
Select watchlists to add or remove PRFX